Company · CIK 0001061983 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
CYTOKINETICS INC · CYTK
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 SForm 4 → | Sep 22, 6:14 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | $68.29 | $239,015 | 153,902 | −2.22% | 10b5-1 |
| Sep 22, 2026 MForm 4 → | Sep 22, 6:14 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | $7.80 | $27,300 | 157,402 | — | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 15, 5:23 pm EDT | Robert E LandryDirector | 1,000 | $72.13 | $72,130 | 8,184 | −10.9% | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 15, 5:20 pm EDT | Robert I BlumPresident & CEO, Director | 105,426 | $69.62 | $7,340,010 | 0 | −100% | 10b5-1 |
| Sep 14, 2026 GMForm 4 → | Sep 15, 5:20 pm EDT | Robert I BlumPresident & CEO, Director | 204,702 | $10.60 | $79,500 | 97,926 | — | 10b5-1 |
| Sep 11, 2026 SForm 4 → | Sep 11, 7:12 pm EDT | Robert E LandryDirector | 1,000 | $74.66 | $74,660 | 9,184 | −9.82% | 10b5-1 |
| Sep 8, 2026 SForm 4 → | Sep 8, 4:38 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | $75.46 | $264,110 | 153,902 | −2.22% | 10b5-1 |
| Sep 8, 2026 MForm 4 → | Sep 8, 4:38 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | $7.80 | $27,300 | 157,402 | — | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 1, 4:51 pm EDT | B Lynne ParshallDirector | 5,000 | $71.48 | $357,400 | 10,784 | −31.7% | 10b5-1 |
| Aug 31, 2026 SForm 4 → | Aug 31, 4:57 pm EDT | Andrew CallosEVP, Chief Commercial Officer | 10,000 | $70.24 | $702,400 | 58,555 | −14.6% | 10b5-1 |
| Aug 31, 2026 MForm 4 → | Aug 31, 4:57 pm EDT | Andrew CallosEVP, Chief Commercial Officer | 10,000 | $23.26 | $232,600 | 68,555 | — | 10b5-1 |
| Aug 31, 2026 SForm 4 → | Aug 31, 4:55 pm EDT | Robert I BlumPresident & CEO, Director | 7,500 | $70.24 | $526,800 | 377,820 | −1.95% | 10b5-1 |
| Aug 31, 2026 MForm 4 → | Aug 31, 4:55 pm EDT | Robert I BlumPresident & CEO, Director | 7,500 | $10.60 | $79,500 | 385,320 | — | 10b5-1 |
| Aug 18, 2026 SForm 4 → | Aug 18, 4:38 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | $75.82 | $265,370 | 153,902 | −2.22% | 10b5-1 |
| Aug 18, 2026 MForm 4 → | Aug 18, 4:38 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | $7.80 | $27,300 | 157,402 | — | 10b5-1 |
| Aug 10, 2026 SForm 4 → | Aug 10, 5:11 pm EDT | Robert I BlumPresident & CEO, Director | 7,500 | $76.76 | $575,700 | 377,820 | −1.95% | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 10, 5:11 pm EDT | Robert I BlumPresident & CEO, Director | 7,500 | $10.60 | $79,500 | 385,320 | — | 10b5-1 |
| Jul 30, 2026 SForm 4 → | Jul 30, 4:26 pm EDT | Andrew CallosEVP, Chief Commercial Officer | 14,000 | $79.88 | $1,118,320 | 58,555 | −19.3% | 10b5-1 |
| Jul 30, 2026 MForm 4 → | Jul 30, 4:26 pm EDT | Andrew CallosEVP, Chief Commercial Officer | 14,000 | $23.26 | $325,640 | 72,555 | — | 10b5-1 |
| Jul 27, 2026 SForm 4 → | Jul 27, 4:33 pm EDT | Robert I BlumPresident & CEO, Director | 7,500 | $80.87 | $606,525 | 377,820 | −1.95% | 10b5-1 |
| Jul 27, 2026 MForm 4 → | Jul 27, 4:33 pm EDT | Robert I BlumPresident & CEO, Director | 7,500 | $10.60 | $79,500 | 385,320 | — | 10b5-1 |
| Jul 21, 2026 SForm 4 → | Jul 23, 4:09 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | $80.59 | $282,065 | 153,902 | −2.22% | 10b5-1 |
| Jul 21, 2026 MForm 4 → | Jul 23, 4:09 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | $7.80 | $27,300 | 157,402 | — | 10b5-1 |
| Jul 15, 2026 AForm 4 → | Jul 16, 4:35 pm EDT | Nancy WysenskiDirector | 75 | $82.62 | $6,197 | 33,992 | — | |
| Jul 15, 2026 AForm 4 → | Jul 16, 4:34 pm EDT | Wendell WierengaDirector | 75 | $82.62 | $6,197 | 35,563 | — | |
| Jul 15, 2026 AForm 4 → | Jul 16, 4:32 pm EDT | Edward M. Kaye M.D.Director | 151 | $82.62 | $12,476 | 10,434 | — | |
| Jul 15, 2026 AForm 4 → | Jul 16, 4:31 pm EDT | John T HendersonDirector | 272 | $82.62 | $22,473 | 78,360 | — | |
| Jul 15, 2026 AForm 4 → | Jul 16, 4:29 pm EDT | Robert Arthur HarringtonDirector | 151 | $82.62 | $12,476 | 21,932 | — | |
| Jul 15, 2026 AForm 4 → | Jul 16, 4:28 pm EDT | James M DalyDirector | 151 | $82.62 | $12,476 | 3,390 | — | |
| Jul 13, 2026 MForm 4 → | Jul 14, 3:34 pm EDT | Robert I BlumPresident & CEO, Director | 7,490 | $10.60 | $79,394 | 385,310 | — | 10b5-1 |
| Jul 13, 2026 SForm 4 → | Jul 14, 3:34 pm EDT | Robert I BlumPresident & CEO, Director | 7,500 | $82.02 | $615,150 | 377,820 | −1.95% | 10b5-1 |
| Jul 7, 2026 SForm 4 → | Jul 7, 5:06 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | $86.62 | $303,170 | 153,902 | −2.22% | 10b5-1 |
| Jul 7, 2026 MForm 4 → | Jul 7, 5:06 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | $7.80 | $27,300 | 157,402 | — | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 2, 5:20 pm EDT | Robert I BlumPresident & CEO, Director | 7,500 | $84.92 | $636,900 | 377,830 | −1.95% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 2, 5:19 pm EDT | Andrew CallosEVP, Chief Commercial Officer | 15,000 | $85.80 | $1,287,000 | 58,555 | −20.4% | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 2, 5:19 pm EDT | Andrew CallosEVP, Chief Commercial Officer | 15,000 | $23.26 | $348,900 | 73,555 | — | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 2, 5:17 pm EDT | Sung LeeEVP, Chief Financial Officer | 1,112 | $87.79 | $97,622 | 63,221 | −1.73% | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 2, 5:17 pm EDT | Sung LeeEVP, Chief Financial Officer | 1,112 | $48.51 | $53,943 | 64,333 | — | 10b5-1 |
| Jun 29, 2026 SForm 4 → | Jun 29, 5:23 pm EDT | Sung LeeEVP, Chief Financial Officer | 3,134 | $85.00 | $266,390 | 63,221 | −4.72% | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jun 29, 5:23 pm EDT | Sung LeeEVP, Chief Financial Officer | 3,134 | $45.83 | $143,643 | 66,355 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 MForm 4 → | Sep 22, 6:14 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | — | — | 23,386 | — | 10b5-1 |
| Sep 14, 2026 MForm 4 → | Sep 15, 5:20 pm EDT | Robert I BlumPresident & CEO, Director | 7,500 | — | — | 156,745 | — | 10b5-1 |
| Sep 8, 2026 MForm 4 → | Sep 8, 4:38 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | — | — | 26,886 | — | 10b5-1 |
| Aug 31, 2026 MForm 4 → | Aug 31, 4:57 pm EDT | Andrew CallosEVP, Chief Commercial Officer | 10,000 | — | — | 0 | — | 10b5-1 |
| Aug 31, 2026 MForm 4 → | Aug 31, 4:55 pm EDT | Robert I BlumPresident & CEO, Director | 7,500 | — | — | 164,245 | — | 10b5-1 |
| Aug 18, 2026 MForm 4 → | Aug 18, 4:38 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | — | — | 30,386 | — | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 10, 5:11 pm EDT | Robert I BlumPresident & CEO, Director | 7,500 | — | — | 171,745 | — | 10b5-1 |
| Jul 30, 2026 MForm 4 → | Jul 30, 4:26 pm EDT | Andrew CallosEVP, Chief Commercial Officer | 14,000 | — | — | 10,000 | — | 10b5-1 |
| Jul 27, 2026 MForm 4 → | Jul 27, 4:33 pm EDT | Robert I BlumPresident & CEO, Director | 7,500 | — | — | 179,245 | — | 10b5-1 |
| Jul 21, 2026 MForm 4 → | Jul 23, 4:09 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | — | — | 33,886 | — | 10b5-1 |
| Jul 13, 2026 MForm 4 → | Jul 14, 3:34 pm EDT | Robert I BlumPresident & CEO, Director | 7,490 | — | — | 186,745 | — | 10b5-1 |
| Jul 7, 2026 MForm 4 → | Jul 7, 5:06 pm EDT | Fady Ibraham MalikEVP Research & Development | 3,500 | — | — | 37,386 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 2, 5:19 pm EDT | Andrew CallosEVP, Chief Commercial Officer | 15,000 | — | — | 24,000 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 2, 5:17 pm EDT | Sung LeeEVP, Chief Financial Officer | 1,112 | — | — | 26,709 | — | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jun 29, 5:23 pm EDT | Sung LeeEVP, Chief Financial Officer | 3,134 | — | — | 39,681 | — | 10b5-1 |